ObsEva

ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapies for serious conditions that impact women's reproductive health and pregnancy. Through strategic licensing and rigorous drug development, ObsEva has built a late-stage clinical pipeline with development programs targeting the treatment of endometriosis, uterine fibroids, preterm labor, and improving ART outcomes.